Skip to main content
Log in

PSURs for biologicals worth their high costs?

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. including all PSUR-related costs for the pharmaceutical industry and regulatory agencies during the 1995−2009 period, assuming a cost between €6000 and €28 000 (2006 values) for one PSUR depending on the number of adverse drug reaction cases (< 100 to > 500)

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

PSURs for biologicals worth their high costs?. PharmacoEcon Outcomes News 676, 5 (2013). https://doi.org/10.1007/s40274-013-0316-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0316-7

Navigation